G&E Herbal Biotechnology (4911.TWO) Earnings Analysis
G&E Herbal Biotechnology (4911.TWO) has no confirmed upcoming earnings date. Trailing P/E 19.28.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4911.TWO next report earnings?
No confirmed upcoming earnings date is currently scheduled for 4911.TWO. This page updates as the calendar is published.
4911.TWO earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
4911.TWO valuation and analyst view
| Trailing P/E | 19.28 |
|---|---|
| Trailing EPS | 1.845 TWD |
| Price / book | 2.34 |
| Dividend yield | 3.70% |
| Market cap | 2.20B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is G&E Herbal Biotechnology (4911.TWO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 4911.TWO. This page updates as the calendar is published.
What is 4911.TWO's current P/E ratio and EPS?
4911.TWO trades at a trailing P/E of 19.28 on trailing EPS of 1.8448210922787194 TWD.
What do analysts rate 4911.TWO?
4911.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.